(Q40478787)

English

Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

object named as

poliovirus

1 reference

based on heuristic

inferred from title

2

object named as

Irja Lutsar

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Sirli Meriste

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Eda Tamm

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Paul Willems

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

350-356

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the toxin neutralization test in mice

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth.

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

Crucial role of antibodies to pertactin in Bordetella pertussis immunity

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

Safety and immunogenicity of combined Dtpa-IPV vaccine for primary and booster vaccination

1 reference

https://api.crossref.org/works/10.1080%2F00365540500488857

21 January 2018

Identifiers

10.1080/00365540500488857

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40478787&oldid=2163962294"